The woolly mammoth has been extinct for thousands of years, but Colossal Biosciences is pursuing technology that could help ...

New research adds to our understanding of the function of the human genome. An international team of researchers has made ...

Anges Inc. has entered into a sponsored research agreement with Stanford University School of Medicine for the development of novel cancer therapies using genome editing technology. The parties aim to ...

CRISPR gene-editing technology presents a possible solution for feeding a growing population, but incorporating CRISPR into ...

EMERYVILLE, Calif. - Metagenomi, Inc. (NASDAQ: MGX), a biotechnology firm specializing in precision genetic medicines trading ...

MGX-001 in Hemophilia A Advances Towards US and Ex-US Regulatory Interactions in 2025NHP Proof-of-Concept Anticipated for Secreted Protein ...

Researchers at the Broad Institute of MIT and Harvard have developed a gene-editing treatment for prion disease that extends ...

The de-extinction company led by CEO Ben Lamm has raked in $435 million in funding since its launch. He believes it has ...

The White House is honoring three Iowa State researchers for their work in artificial intelligence, genome editing and ...

Colossal, a leading biosciences company working to combat environmental dangers and revive extinct species, has reached a new ...

We are excited to welcome Eric to our Board of Directors,” said Brian C. Thomas, PhD, CEO and founder of Metagenomi. “His tremendous track record in the pharmaceutical industry as well as his ...

Researchers at the Broad Institute of MIT and Harvard have developed a gene-editing treatment for prion disease that extends lifespan by about 50 percent in a mouse model of the fatal ...